Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × cemiplimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 44 Melanoma 19 Squamous Cell Carcinoma of Head and Neck 15 Neoplasms 15 Neoplasm Metastasis 15 Skin Neoplasms 11 Lung Neoplasms 10 Recurrence 8 Head and Neck Neoplasms 8 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Colorectal Neoplasms 7 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Breast Neoplasms 6 Adenocarcinoma 6 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Carcinoma, Merkel Cell 5 Carcinoma, Basal Cell 5 Carcinoma 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Glioblastoma 4 Colonic Neoplasms 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Mycosis Fungoides 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3

Interventions

Iodine-131 19 lenvatinib 15 Sorafenib 11 trametinib 10 Thyrotropin Alfa 10 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Thyroidectomy 9 Surgical Procedures, Operative 9 vandetanib 8 dabrafenib 8 Thyroxine 8 Paclitaxel 8 selpercatinib 7 anlotinib 6 Sunitinib 6 Everolimus 6 pazopanib 5 cabozantinib 5 Vemurafenib 5 Triiodothyronine 5 Saline Solution 5 Nivolumab 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 Biopsy, Fine-Needle 5 Radiofrequency Ablation 4 Iodine-124 4 Docetaxel 4 Dexmedetomidine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06902376 2025-11-05

NEO-COMBATXL

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡